Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-02-20 @ 1:35 PM
Study NCT ID:
NCT02993250
Status:
COMPLETED
Last Update Posted:
2019-09-11
First Post:
2016-12-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-13
First Submit QC Date:
None
Study First Post Date:
2016-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-03
Results First Submit QC Date:
None
Results First Post Date:
2019-09-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-10
Last Update Post Date:
2019-09-11
Last Update Post Date Type:
ACTUAL